Table of Contents Author Guidelines Submit a Manuscript
Journal of Chemistry
Volume 2013, Article ID 296792, 6 pages
http://dx.doi.org/10.1155/2013/296792
Research Article

A Convenient Synthesis of C-3-Aryloxymethyl Imidazo[1,2- ]Pyridine Derivatives

1School of Chemistry, University of Hyderabad, Andhra Pradesh, Hyderabad 500046, India
2Department of Chemistry, AG & SG Siddhartha Arts and Science College, Andhra Pradesh, Vuyyuru 521165, India

Received 16 June 2012; Accepted 26 July 2012

Academic Editor: Marco Radi

Copyright © 2013 Sridevi Kona et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. M. Wisniewska, C. B. Rodl, A. S. Kahnt et al., “Molecular characterization of EP6-A novel imidazo[1,2-α]pyridine based direct 5-lipoxygenase inhibitor,” Biochemical Pharmacology, vol. 83, pp. 228–240, 2012. View at Google Scholar
  2. M. Hayakawa, H. Kaizawa, K. Kawaguchi et al., “Synthesis and biological evaluation of imidazo[1,2-α]pyridine derivatives as novel PI3 kinase p110α inhibitors,” Bioorganic and Medicinal Chemistry, vol. 15, pp. 403–412, 2007. View at Google Scholar
  3. R. R. Singhaus, R. C. Bernotas, R. Steffan et al., “3-(3-Aryloxyaryl)imidazo[1,2-α]pyridine sulfones as liver X receptor agonists,” Bioorganic and Medicinal Chemistry Letters, vol. 20, no. 2, pp. 521–525, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Trapani, M. Franco, A. Latrofa et al., “Novel 2-phenylimidazo[1,2-α]pyridine derivatives as potent and selective ligands for peripheral benzodiazepine receptors: Synthesis, binding affinity, and in vivo studies,” Journal of Medicinal Chemistry, vol. 42, no. 19, pp. 3934–3941, 1999. View at Publisher · View at Google Scholar · View at Scopus
  5. S. C. Goodacre, L. J. Street, D. J. Hallett et al., “Imidazo[1,2-α]pyrimidines as functionally selective and orally bioavailable GABAAα2/α3 binding site agonists for the treatment of anxiety disorders,” Journal of Medicinal Chemistry, vol. 49, no. 1, pp. 35–38, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. Z. P. Zhuang, M. P. Kung, A. Wilson et al., “Structure-activity relationship of imidazo[1,2-α]pyridines as ligands for detecting β-amyloid plaques in the brain,” Journal of Medicinal Chemistry, vol. 46, no. 2, pp. 237–243, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Abe, H. Kayakiri, S. Satoh et al., “A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 1. Construction of the basic framework,” Journal of Medicinal Chemistry, vol. 41, no. 4, pp. 564–578, 1998. View at Publisher · View at Google Scholar · View at Scopus
  8. T. H. Al-Tel, R. A. Al-Qawasmeh, and R. Zaarour, “Design, synthesis and in vitro antimicrobial evaluation of novel Imidazo[1,2-α]pyridine and imidazo[2,1-b][1,3]benzothiazole motifs,” European Journal of Medicinal Chemistry, vol. 46, no. 5, pp. 1874–1881, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Gueiffier, M. Lhassani, A. Elhakmaoui et al., “Synthesis of acyclo-C-nucleosides in the imidazo[1,2-α]pyridine and pyrimidine series as antiviral agents,” Journal of Medicinal Chemistry, vol. 39, no. 14, pp. 2856–2859, 1996. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Gueiffier, S. Mavel, M. Lhassani et al., “Synthesis of imidazo[1,2-α]pyridines as antiviral agents,” Journal of Medicinal Chemistry, vol. 41, no. 25, pp. 5108–5112, 1998. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. K. M. Flores, M. E. C. Aldrete, H. S. Zamora, J. C. Basurto, and M. E. M. Camargo, “Docking simulations, synthesis, and anti-inflammatory activity evaluation of 2-(N-alkyl)amino-3-nitroimidazo[1,2-α]pyridines,” Medicinal Chemistry Research, vol. 21, no. 6, pp. 775–782, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Katsura, S. Nishino, Y. Inoue, M. Tomoi, and H. Takasugi, “Studies on antiulcar drugs. II. Synthesis and antiulcer activities of imidazo[1,2-α]pyridinyl-2-alkylaminobenzoxazoles and 5,6,7,8-tetrahydroimidazo[1,2-α]pyridinyl derivatives,” Chemical and Pharmaceutical Bulletin, vol. 40, no. 2, pp. 371–380, 1992. View at Google Scholar · View at Scopus
  13. G. C. Moraski, L. D. Markley, M. Chang et al., “Generation and exploration of new classes of antitubercular agents: the optimization of oxazolines, oxazoles, thiazolines, thiazoles to imidazo[1,2-a]pyridines and isomeric 5,6-fused scaffolds,” Bioorganic and Medicinal Chemistry, vol. 20, pp. 2214–2220, 2012. View at Google Scholar
  14. R. Ducray, I. Simpson, F. H. Jung et al., “Discovery of novel imidazo[1,2-α]pyridines as inhibitors of the insulin-like growth factor-1 receptor tyrosine kinase,” Bioorganic and Medicinal Chemistry Letters, vol. 21, no. 16, pp. 4698–4701, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. M. L. Martínez, H. S. Zamora, M. E. C. Aldrete, J. G. T. Ferrara, J. C. Basurto, and C. M. Ochoa, “Effect of the lipophilic parameter (log P) on the anti-parasitic activity of imidazo[1,2-α]pyridine derivatives,” Medicinal Chemistry Research, pp. 1–6, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. M. A. Ismail, R. Brun, T. Wenzler, F. A. Tanious, W. D. Wilson, and D. W. Boykin, “Novel dicationic imidazo[1,2-α]pyridines and 5,6,7,8-tetrahydro-imidazo[1, 2-α]pyridines as antiprotozoal agents,” Journal of Medicinal Chemistry, vol. 47, no. 14, pp. 3658–3664, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Almirante, L. Polo, A. Mugnaini et al., “Derivatives of imidazole. I. Synthesis and reactions of imidazo[1,2-α]pyridines with analgesic, antiinflammatory, antipyretic, and anticonvulsant activity,” Journal of Medicinal Chemistry, vol. 8, no. 3, pp. 305–312, 1965. View at Google Scholar · View at Scopus
  18. D. Sucunza, A. Samadi, M. Chioua et al., “A practical two-step synthesis of imidazo[1,2-α]pyridines from N-(prop-2-yn-1-yl)pyridin-2-amines,” Chemical Communications, vol. 47, no. 17, pp. 5043–5045, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. Katritzky, A. R. Xu, Y.-J. Tu, and Y. H, “Regiospecific synthesis of 3-substituted imidazo[1,2-α]pyridines, imidazo[1,2-α]pyrimidines and imidazo[1,2-c]pyrimidine,” The Journal of Organic Chemistry, vol. 68,, pp. 4935–4937, 2003. View at Google Scholar
  20. J. Koubachi, S. El Kazzouli, S. Berteina-Raboin, A. Mouaddib, and G. Guillaume, “Synthesis of polysubstituted imidazo[1,2-α]pyridines via microwave-assisted one-pot cyclization/Suzuki coupling/palladium-catalyzed heteroarylation,” Journal of Organic Chemistry, vol. 72, no. 20, pp. 7650–7655, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. V. K. Aggarwal, E. Alonso, I. Bae et al., “A new protocol for the in situ generation of aromatic, heteroaromatic, and unsaturated diazo compounds and its application in catalytic and asymmetric epoxidation of carbonyl compounds. Extensive studies to map out scope and limitations, and rationalization of diastereo- and enantioselectivities,” Journal of the American Chemical Society, vol. 125, no. 36, pp. 10926–10940, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Barluenga, P. Moriel, C. Valdés, and F. Aznar, “N-tosylhydrazones as reagents for cross-coupling reactions: a route to polysubstituted olefins,” Angewandte Chemie, vol. 46, no. 29, pp. 5587–5590, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. X. Zhao, J. Jing, K. Lu, Y. Zhang, and J. Wang, “Pd-catalyzed oxidative cross-coupling of N-tosylhydrazones with arylboronic acids,” Chemical Communications, vol. 46, pp. 1724–1726, 2010. View at Google Scholar
  24. J. Barluenga, M. Tomás-Gamasa, F. Aznar, and C. Valdé, “Straightforward synthesis of ethers: metal-free reductive coupling of tosylhydrazones with alcohols or Phenols,” Angewandte Chemie, vol. 49, no. 29, pp. 4993–4996, 2010. View at Publisher · View at Google Scholar · View at Scopus